Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population.
Sandhya SriramNam-Young KangSubha SubramanianTannistha NandiSamydurai SudhagarQiaorui XingGerine Jin-Ling TongAllen Kuan-Liang ChenThekkeparambil Chandrabose SrijayaPatrick TanYuin-Han LohYoung-Tae ChangShigeki SugiiPublished in: Stem cell research & therapy (2021)
Collectively, BDL-E5 offers a valuable tool for delineating the early reprogramming pathway and clinically applicable commercial production of human iPS cells.